BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 532498)

  • 1. [Pharmacologic influence on secondary generalized fibrinolysis].
    Markwardt F; Drawert J; Perlewitz J
    Acta Biol Med Ger; 1979; 38(8):1201-9. PubMed ID: 532498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunits and susceptibility of fibrins formed from bovine fibrinogen by arvin, reptilase, thrombin and staphylothrombin.
    Zajdel M; Wegrzynowicz Z; Sawecka J; Kopeć M
    Thromb Res; 1975 Apr; 6(4):337-44. PubMed ID: 1169826
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
    Dickneite G; Czech J; Keuper H
    Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of endogenous fibrinolysis inhibition in the dog. Effect of intravascular coagulation and release of free fatty acids.
    Lindquist O; Bagge L; Saldeen T
    Acta Chir Scand; 1976; 142(1):20-5. PubMed ID: 1266538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of fibrin degradation products on different biological tests (author's transl)].
    Vila V; Aznar J; Regañon E
    Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of heparin and defibrase on transplantability of syngeneic tumors in mice.
    Klener P; Bubeník J; Donner L
    Neoplasma; 1978; 25(5):631-5. PubMed ID: 740064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin.
    Teng CM; Ko FN
    Thromb Haemost; 1988 Apr; 59(2):304-9. PubMed ID: 3291184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cleavage and inactivation of plasminogen activator inhibitor type 1 and alpha2-antiplasmin by reptilase, a thrombin-like venom enzyme.
    Urano T; Ihara H; Takada Y; Fujie M; Takada A
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):145-53. PubMed ID: 10759007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of drugs on disseminated intravascular coagulation (DIC). IV. Effects on the thrombin-like enzyme batroxobin on thrombin-induced DIC in rats.
    Markwardt F; Nowak G
    Thromb Res; 1980 Jan 1-15; 17(1-2):103-11. PubMed ID: 6990544
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of fibronectin on fibrinogen conversion into fibrin].
    Litvinov RI; Zubairov DM
    Biokhimiia; 1988 Jul; 53(7):1203-13. PubMed ID: 3179367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reptilase on respiratory insufficiency induced by intravenous infusion of thrombin and AMCA (tranexamic acid) in the dog.
    Busch C; Lindquist O; Saldeen T
    Bibl Anat; 1973; 12():254-9. PubMed ID: 4790359
    [No Abstract]   [Full Text] [Related]  

  • 20. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.